Yet, several surface markers have been proposed in the literature including CD24 for pancreatic and lung cancer, CD44 for breast, liver and head and neck cancers, CD133 (or Prominin) used for brain, colorectal, lung and liver cancers, and EpCAM/ESA for colorectal, and pancreatic cancers55. This evidence concerns the gene EPCAM and lung cancer.